What is CopyPro?
CopyPro operates at the intersection of advanced engineering and life sciences, specializing in the design and manufacture of sophisticated lab automation solutions. The company's core competency lies in optimizing liquid handling, sample preparation, and comprehensive sample management workflows. Through its flagship product lines, such as the firefly and mosquito systems, CopyPro addresses the complex requirements of genomics, drug discovery, and structural biology. By partnering with global research leaders, the company provides the essential tools required to overcome modern laboratory bottlenecks, thereby facilitating faster breakthroughs in human health and scientific discovery.
How much funding has CopyPro raised?
CopyPro has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CopyPro
PPP
Public-Private Partnership
What's next for CopyPro?
With this late-stage capital, CopyPro is poised to transition into a phase of aggressive market expansion and product diversification. The strategic focus will likely shift toward enhancing its global distribution network and deepening its R&D capabilities to address emerging challenges in high-throughput screening. As the demand for automated, reliable, and efficient laboratory workflows continues to rise, CopyPro is strategically aligned to capture additional market share. The company's roadmap suggests a continued commitment to co-creating innovative solutions that integrate seamlessly into existing research ecosystems, ensuring long-term sustainability and technological dominance in the life sciences instrumentation market.
See full CopyPro company page
